Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

The case shows skin changes can indicate deeper health issues like insulin resistance, which are challenging to manage.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

AGA patients have lower serum vaspin levels, which might help detect the condition early.

More severe hair loss worsens quality of life in men.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

A peptide from hair follicle stem cells promotes hair growth by activating specific skin cells.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

ASLNC168501 can help treat hair loss by restoring hair follicle stem cell function.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

New model shows muscle affects hair loss differently in men and women.

Some hair growth cells remain in partially bald areas of Indian men with hair loss.

The treatment is safe and very effective for hair growth in Asian men with minimal side effects.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

New drug targets for hair loss treatment were identified by studying cell interactions in hair follicles.

Alopecia areata often starts before age 20, is more common in women, and may have a genetic link with other autoimmune diseases.

Early-onset male hair loss is linked to metabolic syndrome, suggesting a need for heart health monitoring and lifestyle changes.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

Hair loss in men might be linked to programmed cell death.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

AI can help track and improve hair loss treatment outcomes.

Hair loss might be linked to eye aging due to inflammation markers in blood.